With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to ...

Ildong Pharmaceutical Group announced on November 3 that it will participate in the '2025 BIO-Europe,' where it will showcase ...

Vesper Bio announces positive Phase Ib/IIa topline results for lead candidate VES001 for frontotemporal degeneration Phase Ib/IIa study found VES001, the first oral therapy being tested in FTD, led to ...

All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the ...

By completing its second bio campus (plants 5 through 8) by 2032, the company aims to maintain a production ... We will ...

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...

Just after 6 p.m. on a brisk mid-October evening, the hum of conversation filled a physics lab at South Seattle College. Mateo Moreno-McQuarrie leaned over ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biopharmaceutical company announced today that Seth Lederman, M.D., Chief Executive Officer ...

Ayurveda Integrated into Science Education In a groundbreaking initiative, the National Council of Educational Research and ...

I was born in Mississippi to Indian-immigrant parents who came here in the late 1960s, drawn by the promise of American ...

One of Collins’ biggest achievements in office was luring a Toyota plant to Georgetown, a move that created thousands of jobs ...